TITLE

U.S. pays $4.8 million settlement for radiation experiments on humans

PUB. DATE
December 1996
SOURCE
Jet;12/09/96, Vol. 91 Issue 4, p12
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports on United States Energy Secretary Hazel O'Leary's announcement of a $4.8 million settlement with the families of people injected with radiation during medical experiments in the 1940s. Amount of money given to each of the eleven families and the one survivor; Details behind the injections; Claims from the scientists about the health of the victims.
ACCESSION #
9612137526

 

Related Articles

  • Sanctions agreed over teenager's gene-therapy death. Check, Erika // Nature;2/17/2005, Vol. 433 Issue 7027, p674 

    Reports on the sanctions faced by researchers involved in a gene-therapy trial leading to a teenagers death in 1999 in the U.S. Estimated amount agreed for the out-of-court settlement on the case; Terms of the agreement included in the settlement; Basis of the court's decision.

  • The `hole in the bucket' in medical care the Peckham experiment was not permitted to repair... Aitchtey, Rodney // Contemporary Review;May95, Vol. 266 Issue 1552, p236 

    Discusses the creation of the Pioneer Health Center in Queen's Road in Peckham, London, England in 1935 by Doctors Innes H. Pearse and George Scott Williamson which became known as Peckham Experiment. Ethological interest of the doctors in England; Limitations imposed by upbringing; Conditions...

  • Untitled.  // IRB Advisor;Mar2007, Vol. 7 Issue 3, p36 

    The section presents a quiz related to human research protection and adverse events.

  • YOUR INNER ARTIST. Haseltine, Eric // Discover;Jun2002, Vol. 23 Issue 6, p88 

    Presents scientific experiments on the human brain. Creation of sketch for the picture of Abraham Lincoln; Role of left hemisphere in recognizing figures; Facial contour tracing.

  • Bispecific antibodies may reduce metastases, PSA levels. Bauman, Norman // Urology Times;Jan98, Vol. 26 Issue 1, p34 

    Discloses the phase II clinical trials of the HER-2/neu oncogene expression for radical prostatectomy patients. Experimental procedure; Goal of reducing 5-year recurrence rate of tumor; Similarity of phase I and phase II toxicity treatments.

  • Corrections and clarifications.  // BMJ: British Medical Journal (International Edition);5/28/2005, Vol. 330 Issue 7502, p1258 

    Presents corrections to the April 23, 2005 articles "Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1)" and "Two drug firms advertised to patients," and the April 30 article "National survey...

  • Radiation damages.  // New Scientist;11/30/96, Vol. 152 Issue 2058, p10 

    Reports on the compensation of the families of people injected with radioactive isotopes without their consent in secret Cold War experiments in the United States.

  • Health trials: Employees should know what they're in for.  // Industrial Safety & Hygiene News;Jul2002, Vol. 36 Issue 7, p16 

    Explores how well-informed volunteers for clinical trials are. Knowledge on the risks of study participation; Percentage of volunteers who didn't know what to ask at the onset of the trial.

  • Office for Human Research Protections (OHRP) Research Community Forum (RCF).  // Biomedical Market Newsletter;6/1/2012, Vol. 21, p1 

    The article informs that the Office for Human Research Protections will be hosting Research Community Forum on June 22, 2012 in Pittsburgh, Pennsylvania.

  • Mass drug overdose - none dead.  // New Scientist;2/6/2010, Vol. 205 Issue 2746, p7 

    The article reports on the 10:23 campaign aimed at highlighting the alleged ineffectiveness of homeopathic remedies which involved volunteers in several countries such as Great Britain, Australia, and New Zealand.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics